Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Showing
41-60 of 179
Cuba Pharmaceuticals & Healthcare Report

Cuba Pharmaceuticals & Healthcare Report

BMI View: Cuba's pharmaceutical spending will continue to grow over the forecast period, driven by an ageing population and the rising demand for chronic disease treatment. However, economic headwinds and the slow pace of ...
$1,375.00
Read More
Czech Republic Pharmaceuticals & Healthcare Report

Czech Republic Pharmaceuticals & Healthcare Report

BMI View: The Czech Republic's pharmaceutical market continues to move toward closer alignment with Western European market trends . H ealthcare and medicine expenditure growth will underperform relative to its less-developed regional peers . H owever ...
$1,375.00
Read More
Denmark Pharmaceuticals & Healthcare Report

Denmark Pharmaceuticals & Healthcare Report

BMI View : Denmark's pharmaceutical market is expected to maintain a moderate but steady growth trajectory over our forecast. An ageing population and rising obesity levels, which will contribute to an increase in chronic diseases, ...
$1,375.00
Read More
Ecuador Pharmaceuticals & Healthcare Report

Ecuador Pharmaceuticals & Healthcare Report

BMI View: Ecuador's pharmaceutical and healthcare markets will continue to grow at a moderate pace over the coming years, yet , given the level of underdevelopment, commercial incentives for foreign drugmakers will remain mainly limited ...
$1,375.00
Read More
Egypt Pharmaceuticals & Healthcare Report

Egypt Pharmaceuticals & Healthcare Report

BMI View: Increasing efforts from the Egyptian government to develop the national pharmaceutical sector will bode well for the market's long-term attractiveness to investors. Key drivers underpinning the market's trajectory include the country' ...
$1,375.00
Read More
El Salvador Pharmaceuticals & Healthcare Report

El Salvador Pharmaceuticals & Healthcare Report

BMI View: El Salvador continues to take necessary measures en route to becoming a significant player in the Central American pharmaceutical market. Government reforms have bolstered investment in a wide range of health infrastructure, resulting ...
$1,375.00
Read More
Estonia Pharmaceuticals & Healthcare Report

Estonia Pharmaceuticals & Healthcare Report

BMI View: The outlook for healthcare and pharmaceutical expenditure growth in Estonia is relatively strong, driven by the country's ageing demographics, which will continue to grow demand for medicines. However, the country's small ...
$1,375.00
Read More
Ethiopia Pharmaceuticals & Healthcare Report

Ethiopia Pharmaceuticals & Healthcare Report

BMI View : Ethiopia's pharmaceutical market has relatively strong long-term potential in Sub-Saharan Africa on account of its strong manufacturing sector and large population, yet in the near-medium-term offers limited drugmaker opportunities. Reflective of the ...
$1,375.00
Read More
Europe Pharmaceuticals & Healthcare Report

Europe Pharmaceuticals & Healthcare Report

BMI View: The Europe region will continue to attract significant investment from multinational pharmaceutical firms. Differing trends in Western and Emerging Europe sub-regions will create different opportunities. The more developed Western markets will continue to ...
$1,375.00
Read More
Finland Pharmaceuticals & Healthcare Report

Finland Pharmaceuticals & Healthcare Report

BMI View: Pharmaceutical sector growth in Finland will slow over the next decade as the market matures. The country's high per-capita spending coupled with a rapidly aging population and rising obesity levels - which ...
$1,375.00
Read More
France Pharmaceuticals & Healthcare Report

France Pharmaceuticals & Healthcare Report

BMI View: Despite cost-control efforts targeting pharmaceutical spending, France will remain a key market in Western Europe, given its high spending per capita on medicine and strong market growth fundamentals. In fact, we expect France' ...
$1,375.00
Read More
Gabon Pharmaceuticals & Healthcare Report

Gabon Pharmaceuticals & Healthcare Report

BMI View : As one of the smaller pharmaceutical markets in Sub-Saharan Africa, Gabon will continue to be viewed as a relatively unattractive destination for the sale of high-value drugs by innovative drugmakers. The market dynamics ...
$1,375.00
Read More
Georgia Pharmaceuticals & Healthcare Report

Georgia Pharmaceuticals & Healthcare Report

BMI View: Georgia will remain a marginal market for major drug firms, not least due to its modest population size. Nevertheless, favourable business climate will continue to promote interest in the country's pharmaceutical market. ...
$1,375.00
Read More
Germany Pharmaceuticals & Healthcare Report

Germany Pharmaceuticals & Healthcare Report

BMI View: Despite the strong focus on cost-containment in relation to pharmaceutical expenditure, we continue to view Germany as one of the key Western European markets. High per capita healthcare and pharmaceutical spend and high ...
$1,375.00
Read More
Ghana Pharmaceuticals & Healthcare Report

Ghana Pharmaceuticals & Healthcare Report

BMI View: Proposals to boost domestic drugmakers' manufacturing capabilities in Ghana and limit the overall medicine bill will be supported by a more proactive stance taken by the Ghanaian government. This also makes up part ...
$1,375.00
Read More
Global Pharmaceuticals & Healthcare Report

Global Pharmaceuticals & Healthcare Report

BMI View: The global pharmaceutical market will be increasingly influenced by a wide spectrum of stakeholders. Regulators are seeking ways to accelerate approval process. Governments are constantly balancing demands for new treatments with budgetary constraints. ...
$1,375.00
Read More
Greece Pharmaceuticals & Healthcare Report

Greece Pharmaceuticals & Healthcare Report

BMI View: Multinational pharmaceutical firms will continue to face considerable challenges in Greece. The healthcare system as a whole will continue to struggle due to a lack of funding , resulting in high levels of debt. ...
$1,375.00
Read More
Guatemala Pharmaceuticals & Healthcare Report

Guatemala Pharmaceuticals & Healthcare Report

BMI View: Guatemala's pharmaceutical market is forecast to post a high growth rate over the coming five years, providing greater commercial opportunities for foreign drugmakers. Given the level of underdevelopment, commercial incentives for foreign ...
$1,375.00
Read More
Honduras Pharmaceuticals & Healthcare Report

Honduras Pharmaceuticals & Healthcare Report

BMI View: Honduras has one of the smallest pharmaceutical markets in the region. The country's under funded healthcare system, weak regulatory environment and low levels of affordability limit innovative medicine sales. Although Honduras ' developing ...
$1,375.00
Read More
Hong Kong Pharmaceuticals & Healthcare Report

Hong Kong Pharmaceuticals & Healthcare Report

BMI View: While Hong Kong's pharmaceutical market remains small in comparison to other Asia-Pacific countries due to its small population, it will continue to show solid potential for substantial growth. The city's ageing ...
$1,375.00
Read More
Showing
41-60 of 179